Page last updated: 2024-10-21

5,8,11,14-eicosatetraynoic acid and Hepatoblastoma

5,8,11,14-eicosatetraynoic acid has been researched along with Hepatoblastoma in 1 studies

5,8,11,14-Eicosatetraynoic Acid: A 20-carbon unsaturated fatty acid containing 4 alkyne bonds. It inhibits the enzymatic conversion of arachidonic acid to prostaglandins E(2) and F(2a).

Hepatoblastoma: A malignant neoplasm occurring in young children, primarily in the liver, composed of tissue resembling embryonal or fetal hepatic epithelium, or mixed epithelial and mesenchymal tissues. (Stedman, 25th ed)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Vu-Dac, N1
Schoonjans, K1
Kosykh, V1
Dallongeville, J1
Fruchart, JC1
Staels, B1
Auwerx, J1

Trials

1 trial available for 5,8,11,14-eicosatetraynoic acid and Hepatoblastoma

ArticleYear
Fibrates increase human apolipoprotein A-II expression through activation of the peroxisome proliferator-activated receptor.
    The Journal of clinical investigation, 1995, Volume: 96, Issue:2

    Topics: 5,8,11,14-Eicosatetraynoic Acid; Adult; Apolipoprotein A-II; Apolipoproteins E; Base Sequence; Cells

1995